Results 101 to 110 of about 84,996 (200)

Compliance with RSV prophylaxis: Global physicians’ perspectives

open access: yes, 2009
Kari S Anderson, Victoria M Mullally, Linda M Fredrick, Andrew L CampbellAbbott Laboratories, Abbott Park, IL, USAAbstract: Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants.
Kari S Anderson   +3 more
core  

Adjuvanted RSVPreF3 vaccine impact over three respiratory syncytial virus seasons in older adults with comorbidities. [PDF]

open access: yesERJ Open Res
Papi A   +15 more
europepmc   +1 more source

Epidemiology of human RSV in Taiwan, 2018-2024. [PDF]

open access: yesPLoS One
Yang SL   +6 more
europepmc   +1 more source

Respiratory Syncytial Virus Vaccination Strongly Induces RSVpreF-specific IgG and Neutralizing Activity in Immunocompromised Individuals. [PDF]

open access: yesTransplant Direct
Bronder S   +10 more
europepmc   +1 more source

Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024). [PDF]

open access: yesPLoS One
de Veras BMG   +8 more
europepmc   +1 more source

Long-term stability of the GMP-compliant recombinant BCG vaccine against human RSV under quality control analyses. [PDF]

open access: yesiScience
Troncoso-Bravo T   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy